U.S. Markets closed

OncoSec Medical Incorporated (ONCS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.19+0.28 (+5.70%)
At close: 1:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 2.55
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 35.77
52 Week Low 31.04
50-Day Moving Average 34.44
200-Day Moving Average 33.43

Share Statistics

Avg Vol (3 month) 3270.54k
Avg Vol (10 day) 3191.52k
Shares Outstanding 527.69M
Float 11.67M
% Held by Insiders 157.86%
% Held by Institutions 17.91%
Shares Short (Nov 12, 2020) 4523.01k
Short Ratio (Nov 12, 2020) 41.38
Short % of Float (Nov 12, 2020) 43.33%
Short % of Shares Outstanding (Nov 12, 2020) 41.89%
Shares Short (prior month Oct 14, 2020) 4266.06k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3May 20, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul 30, 2020
Most Recent Quarter (mrq)Jul 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-90.75%
Return on Equity (ttm)-221.51%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -43.19M
Net Income Avi to Common (ttm)-42.25M
Diluted EPS (ttm)-2.56
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)20.35M
Total Cash Per Share (mrq)0.74
Total Debt (mrq)7.82M
Total Debt/Equity (mrq)56.41
Current Ratio (mrq)2.36
Book Value Per Share (mrq)0.60

Cash Flow Statement

Operating Cash Flow (ttm)-33.15M
Levered Free Cash Flow (ttm)-17.49M